PLK1 and cancer: Subsequently, the overexpression of PLK1 is frequently linked to poor prognosis and its predominantly limited treatment choices, making it a potential target for cancer diagnostics and therapeutics (Wierer et al., 2013; Kahl et al., 2022; Kandala et al., 2023; Wang et al., 2025).